Coming Soon-DelveInsight New Report Antibody-Drug Conjugate Global Market and Pipeline Outlook, 2015

March 11, 2015 - PRLog -- DelveInsight, the leading Business consultant and Market Research Firm is proud to announce the pre-launch of it Report: Antibody-Drug Conjugate-Global Market and Pipeline Outlook, 2015. The Report has highlighted the Antibody drug conjugate technologies, novel ADC platforms, novel payloads, linkers, company’s collaborations and descriptive ADCs Pipeline profiles.

Antibody-Drug Conjugates report has uncovered the potential of global ADC Market with insights into 6 Therapy Areas with collective pipeline of more than 264 ADCs and the companies at their forefront. The Report has also provided the core information of the targets, mechanism of action, development partner, technology partner, monoclonal antibody used, linker used and cytotoxic drug with the descriptive information of the technologies. The Report has also assessed the ADCs on geographical distribution based on the country and region.

DelveInsight is also giving a limited period Pre-Launch offer of USD 500 off on this Report. The Report is available at USD 3500 as a single user license, USD 7000 as a site license and USD 10500 as a Global/Enterprise License.

Book now for maximum appreciation of your investment!

For more information, email at info@delveInsight.com

About DelveInsight

DelveInsight is a Business Consultant company and serve as a Knowledge partner across the value chain of Pharmaceutical Industry. With the use of proprietary databases and analytical models, DelveInsight provides cutting-edge market and pipeline analysis and API intelligence across all therapy areas to the Pharma and biotech sector, helping clients to quantify market events and evaluate their impact on the valuation of products, portfolios and companies.

Additional information is available at www.delveinsight.com